Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188235 | SCV000241843 | benign | not specified | 2014-08-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000188235 | SCV000248283 | uncertain significance | not specified | 2015-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088099 | SCV000562382 | benign | Pitt-Hopkins-like syndrome 2 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317128 | SCV000850593 | likely benign | Inborn genetic diseases | 2017-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000727636 | SCV000854919 | uncertain significance | not provided | 2018-04-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727636 | SCV004146127 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | NRXN1: BP4 |